Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$25,000.00
Sep 28, 2020
For-profit organization
Cyber Security Assistance
957299
This project will provide cyber security assistance to a priority covid response firm.
$1,000,000.00
Sep 17, 2020
215122
215122
Support pre-clinical development activities for COVID-19 vaccine
$900,000.00
Sep 17, 2020
215122
215122
Support pre-clinical development activities for COVID-19 vaccine
$2,655,429.00
Sep 4, 2020
For-profit organization
COVID-19 Response (VI): DPX-COVID-19 Clinical Development and DPX-CoVLP Proof-of-Concept Study
957553
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted peptide epitope approach has the potential to optimize and exceed the safety and efficacy profile of more conventional vaccines. DPX-COVID-19 utilizes a multi-target approach, to optimize immune response against virus’ weaknesses, enhance efficacy at preventing infection and reduce potential for immune escape, even in case of a virus mutation. Fully synthetic, DPX-COVID-19 has the potential for fast and large-scale manufacturing to supply a significant number of doses rapidly compared to more conventional vaccines.
$636,596.00
Apr 1, 2020
For-profit organization
Covid-19 Response: DPX-COVID-19: Neutralizing-epitope Based Synthetic Vaccine with Potential for Large Scale Production
948901
This project aims to establish the clinical safety and immunogenicity of a vaccine candidate based on the Company’s DPX delivery technology and incorporating peptides targeting novel epitopes from the coronavirus strain. IMV believes that this peptide-based approach, combined with the portability of the DPX platform, offers the potential for accelerated development and rapid, large-scale production of a vaccine.
$640,332.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
951167
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$4,500.00
May 7, 2018
Individual or sole proprietorship
Experience Awards
11020182019Q21021
NSERC’s Experience Awards (previously Industrial Undergraduate Student Research Awards [IUSRA]) offer organizations access to talented natural sciences and engineering undergraduate students for a work term. This cost-shared program allows students to address organization-specific R&D challenges while gaining valuable industrial experience. Experience Awards also let organizations identify potential future full-time employees.
$4,218.75
Sep 20, 2017
Screening for immunogenic antigens for Zika virus vaccine
USRAI